| 000 | 01752 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514004443.0 | ||
| 264 | 0 | _c20011011 | |
| 008 | 200110s 0 0 eng d | ||
| 022 | _a0931-0509 | ||
| 024 | 7 |
_a10.1093/ndt/16.8.1592 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLopau, K | |
| 245 | 0 | 0 |
_aHaemodynamic effects of valsartan in acute renal ischaemia/reperfusion injury. _h[electronic resource] |
| 260 |
_bNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association _cAug 2001 |
||
| 300 |
_a1592-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAngiotensin Receptor Antagonists |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHemodynamics _xdrug effects |
| 650 | 0 | 4 |
_aIschemia _xphysiopathology |
| 650 | 0 | 4 |
_aKidney Glomerulus _xphysiopathology |
| 650 | 0 | 4 |
_aMicrocirculation _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aReceptor, Angiotensin, Type 1 |
| 650 | 0 | 4 | _aReceptor, Angiotensin, Type 2 |
| 650 | 0 | 4 |
_aRenal Circulation _xdrug effects |
| 650 | 0 | 4 |
_aReperfusion Injury _xphysiopathology |
| 650 | 0 | 4 |
_aTetrazoles _xpharmacology |
| 650 | 0 | 4 |
_aValine _xanalogs & derivatives |
| 650 | 0 | 4 | _aValsartan |
| 700 | 1 | _aHefner, L | |
| 700 | 1 | _aBender, G | |
| 700 | 1 | _aHeidbreder, E | |
| 700 | 1 | _aWanner, C | |
| 773 | 0 |
_tNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association _gvol. 16 _gno. 8 _gp. 1592-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/ndt/16.8.1592 _zAvailable from publisher's website |
| 999 |
_c11404410 _d11404410 |
||